InQpharm Group
🇲🇾Malaysia
- Country
- 🇲🇾Malaysia
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.inqpharm.com
Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn
Phase 4
Completed
- Conditions
- Postprandial Heartburn
- Interventions
- Device: IQP-LH-101 tabletDevice: IQP-LH-101 liquidOther: Placebo
- First Posted Date
- 2012-10-31
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 41
- Registration Number
- NCT01718639
- Locations
- 🇩🇪
Weißenseerweg 111, Berlin, Germany
Efficacy and Safety of IQP-VV-102 in Weight Management
Phase 3
Completed
- Conditions
- OverweightObesity
- Interventions
- Dietary Supplement: IQP-VV-102Other: Placebo
- First Posted Date
- 2012-09-07
- Last Posted Date
- 2015-11-06
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 120
- Registration Number
- NCT01681069
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
Effect of Litramine on Fat Excretion
Phase 4
Completed
- Conditions
- Healthy Subjects
- Interventions
- Device: LitramineDevice: Placebo
- First Posted Date
- 2012-05-03
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 20
- Registration Number
- NCT01590667
- Locations
- 🇩🇪
Weißenseer Weg 111, Berlin, Germany
Litramine in Weight Maintenance
Phase 4
Completed
- Conditions
- OverweightWeight MaintenanceObese
- Interventions
- Dietary Supplement: LitramineDietary Supplement: Placebo
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2015-06-01
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 50
- Registration Number
- NCT01505387
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
Nasya in Allergic Rhinitis
Phase 3
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- Device: Saline solutionDevice: Nasya
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 20
- Registration Number
- NCT01503957
- Locations
- 🇩🇪
Campus Charité Mitte Klinik und Poliklinik für Hals-, Nasen-, Ohren- heilkunde Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
Efficacy and Safety of Glucosanol in Maintaining Body Weight
Phase 4
Completed
- Conditions
- OverweightObesity
- Interventions
- Device: Glucosanol
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 51
- Registration Number
- NCT01435278
- Locations
- 🇩🇪
Barbara Grube, MD, Berlin, Germany
Efficacy and Safety of Zenoctil in Reducing Body Weight
Phase 3
Completed
- Conditions
- Overweight
- Interventions
- Dietary Supplement: ZenoctilOther: Placebo
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 92
- Registration Number
- NCT01423617
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects
Phase 4
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Device: PlaceboDevice: Glucosanol
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 124
- Registration Number
- NCT01407393
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
Safety and Efficacy of Litramine in Overweight and Obese Subjects
Phase 3
Completed
- Conditions
- OverweightObesityWeight Loss
- Interventions
- Device: LitramineDevice: Placebo
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2011-10-13
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 125
- Registration Number
- NCT01233349
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath